• Korean Journal of Clinical Pharmacy
• /
• v.28 no.3
• /
• pp.181-187
• /
• 2018

Background: Posaconazole is a broad-spectrum triazole antifungal agent and the most recommended prophylactic antifungal agent for patients with acute myeloid leukemia (AML) undergoing induction chemotherapy. In this study, we evaluated the status and effectiveness of posaconazole as a prophylactic antifungal agent in pediatric patients receiving induction chemotherapy for AML. Methods: We retrospectively reviewed the electronic medical records of 36 pediatric patients with AML (between January 2013 and September 2017) at the Yonsei University Health System. Invasive fungal disease (IFD) was assessed as the primary endpoint of prophylactic antifungal effect. The secondary endpoints were incidence of fever, persistent fever despite the use of broad-spectrum antibiotics for 72 h, alteration of antifungal agent, intensive care unit admission, and death within 100 days. Results: Among the 36 patients, 18 patients used posaconazole, 12 were treated with suspension formula, and 6 of them were treated with tablets. Eighteen patients did not use antifungal agents prophylactically. The mean number of days of posaconazole administration was $26.8{\pm}16days$. IFD occurred in 2/18 (11.1%) patients in the no prophylaxis group and in 1/18 (5.6%) patients in the posaconazole group (p=0.49). Conclusion: Posaconazole is expected to be useful for the prevention of IFD in pediatric patients with AML undergoing induction chemotherapy. Prospective studies of the effectiveness of posaconazole prophylaxis should be conducted in more pediatric patients in the future.

• Korean Journal of Clinical Pharmacy
• /
• v.30 no.3
• /
• pp.161-168
• /
• 2020

Background: Recently, a study comprising adult patients with sepsis admitted in the intensive care unit (ICU) was conducted. The patients were treated with high doses of intravenous ascorbic acid, thiamine, and hydrocortisone; the clinical outcomes demonstrated significant therapeutic benefits. The mortality rate in children with sepsis is approximately 25%. However, the effects of additional treatment with ascorbic acid and thiamine ("vitamin protocol") in children are rarely investigated. Methods: A retrospective analysis was performed using medical records of patients diagnosed with sepsis and admitted to the pediatric ICU (PICU) between September 2016 and June 2019. The control group received treatment only as per sepsis protocol, whereas the treated group received both sepsis protocol and the vitamin protocol. The primary endpoint was change in Vasoactive-Inotropic Score (VIS) for 5 days. The secondary endpoints included the length of stay in the PICU, duration of using mechanical ventilators and vasopressors, and mortality rate. Results: The number of patients in the treated and control groups was 33 and 24, respectively. The treated group showed greater decrease in their VIS for 5 days than the control group (44.4 vs 18.6); however, the difference was not statistically significant. The length of stay in the PICU was significantly longer for the treated group than for the control group [10.0 days (Interquartile range (IQR), 6-18) vs 4.5 days (IQR, 4-10.3); p=0.004]. Conclusions: No significant treatment benefits were observed following vitamin protocol administration to the pediatric patients with sepsis. Further studies are necessary for improving the efficacy and safety of the vitamin protocol.

• Journal of the Korean Institute of Gas
• /
• v.20 no.2
• /
• pp.49-57
• /
• 2016

Aqueous ammonia is widely used in household cleaners, fertilizers and denitrification process. It is usually treated in concentrations from 10 % to 30 %, and release accidents have occurred frequently. In this study, we developed a simplified estimating method and equation to calculate threat zone easily in case of emergency due to release accident of aqueous ammonia. We calculated the consequence distance for toxic endpoints of aqueous ammonia(concentration 10 % ~ 30 %) at different puddle areas($1m^2{\sim}500m^2$) using the ALOHA program. Based on the result, we analyzed the relationship between concentration and puddle area with the threat zone and created the equation.

• Asian Pacific Journal of Cancer Prevention
• /
• v.14 no.8
• /
• pp.4835-4838
• /
• 2013

Background: We compared treatment completion rates and safety of docetaxel and cyclophosphamide sixcycle therapy (TC6) with docetaxel followed by 5FU, epirubicin and cyclophosphamide (T-FEC) therapy in Japanese patients with human epidermal growth factor receptor 2 (HER2)-negative breast cancer. Materials and Methods: We administered TC6 q3w or T-FEC q3w to HER2-negative breast cancer patients. The primary endpoint of this trial was toxicity. As second endpoints, the treatment completion rate and relative dose intensity were evaluated. Results: The TC6 and T-FEC group consisted of 22 and 21 patients, respectively. Concerning hematological toxicity, grade 3 or higher adverse reactions included neutropenia and febrile neutropenia. As non-hematological adverse events, exanthema and peripheral neuropathy were frequently reported in the TC6 group, whereas more patients of the T-FEC group reported nausea and vomiting. In TC6, the treatment completion rate was 86.4% and the relative dose intensity of docetaxel was 93.2%. In T-FEC, the values were 95.2% and 98.9%, respectively. Conclusions: These results suggest that TC6 is tolerable in Japanese, and that this regimen can also be performed in outpatient clinics. However, with the TC6 regimen, the compliance was slightly lower than with the T-FEC regimen, and supportive therapy needs to be managed appropriately.

• Asian Pacific Journal of Cancer Prevention
• /
• v.17 no.7
• /
• pp.3155-3160
• /
• 2016

Background: L-asparaginase (ASNase) is commonly used in the treatment of acute lymphoblastic leukemia (ALL) and natural killer (NK)/T-cell lymphoma. This study was designed to describe the incidence of toxicity associated with ASNase in Asian adults. Secondary objectives were to investigate the management and impact of toxicity on subsequent ASNase use, and to compare the actual management against current recommendations. Materials and Methods: In this retrospective, multi-center, observational study, Asian patients ${\geq}18$ years old who received ${\geq}1$ dose of the native E. coli ASNase from 2008 to 2013 were included. Patients were excluded if they did not receive ASNase. Endpoints of this study were development of specific toxicities, whether ASNase was discontinued or re-challenged, and developmentg of recurrent toxicity. All data analyses were performed using SPSS version 20.0. Results: A total of 56 patients were analyzed. Mean (${\pm}SD$) age was 36.2 (${\pm}15.2$) years old, with 62.5% being males, 55.4% with ALL and 28.6% with NK/T-cell lymphoma. Hypersensitivity (12.5%) was associated with the highest incidence of toxicity (6 out of 7 patients had Grade 3 and 4 toxicity), followed by 10.7% for hepatic transaminitis, 3.6% for non-CNS thrombosis and 1.8% each for hyperbilirubinemia and pancreatitis. Hypersensitivity recurred in the 3 patients who were re-challenged with E. coli ASNase. Conclusions: ASNase is associated with a wide range of toxicities, with hypersensitivity being the most commonly observed among Asian adult patients.

• International Journal of CAD/CAM
• /
• v.13 no.1
• /
• pp.1-11
• /
• 2013

Just by adjusting the control points iteratively, progressive iterative approximation (PIA) presents an intuitive and straightforward scheme such that the resulting limit curve (surface) can interpolate the original data points. In order to obtain more flexibility, adjusting only a subset of the control points, a new method called local progressive iterative approximation (LPIA) has also been proposed. But to this day, there are two problems about PIA and LPIA: (1) Only an approximation process is discussed, but the accurate convergence curves (surfaces) are not given. (2) In order to obtain an interpolating curve (surface) with high accuracy, recursion computations are needed time after time, which result in a large workload. To overcome these limitations, this paper gives an explicit matrix expression of the control points of the limit curve (surface) by the PIA or LPIA method, and proves that the column vector consisting of the control points of the PIA's limit curve (or surface) can be obtained by multiplying the column vector consisting of the original data points on the left by the inverse matrix of the collocation matrix (or the Kronecker product of the collocation matrices in two direction) of the blending basis at the parametric values chosen by the original data points. Analogously, the control points of the LPIA's limit curve (or surface) can also be calculated by one-step. Furthermore, the $G^1$ joining conditions between two adjacent limit curves obtained from two neighboring data points sets are derived. Finally, a simple LPIA method is given to make the given tangential conditions at the endpoints can be satisfied by the limit curve.

• Journal of KIISE:Computing Practices and Letters
• /
• v.14 no.4
• /
• pp.389-400
• /
• 2008

As the wireless network technologies and the capability of the mobile terminals are evolving, advanced peer to peer applications for mobile users are attracting interests. In this paper, we propose the mobile P2P communication platform(MPCP) which provides transparency to the wireless network technologies and solutions to the limited resources of the mobile terminals. MPCP classifies the connection into two levels: a virtual channel and a session. A virtual channel is the network layer connection between the terminals whereas a session is the application layer connection. MPCP classifies the sessions into four types and applies different scheduling priority and data processing policies such as segmentation and reassembly. It selects proper wireless network technologies depending on the distance between the communication endpoints. To acquire dynamically changed access address, we harness the Session Initiation Protocol. We implemented MPCP on embedded Linux simulator and utilized the implementation in mobile P2P service development. For the quantitative analysis, we compared the performance of MPCP with that of ftp. Regardless of the number of simultaneous sessions, MPCP maintains the relative performance.

• The Korean Journal of Pain
• /
• v.12 no.1
• /
• pp.48-53
• /
• 1999

Background: Despite the popularity of epidural bupivacaine-morphine infusions for postoperative pain management, the optimum concentrations and dosages of bupivacaine have not been determined. At present, due to the disadvantages conferred by intense motor block and the increased risk of toxicity, many trials focus on reducing bupivacaine concentration and thus the evaluation of concentrations less than 0.1% may be warranted. Methods: Forty patients having epiduro-general anesthesia for hysterectomy were randomly assigned to one of two study groups. As a mean of postoperative pain control, all received 2 mg of epidural morphine bolusly 1 hr before the end of surgery and continuous epidural infusion was started using a two-day Infusor containing 4 mg of morphine in 100 ml of 0.125% bupivacaine (Group 0.125B, n=20) or 100 ml of 0.0625% bupivacaine (Group 0.0625B, n=20). Study endpoints included visual analog scales (VAS) for pain during rest and movement, sensory change and motor blockade. They were assessed at 2, 4, 8, 16, 24, 32, 40 and 48 hrs postoperatively. Results: For VAS during rest, no significance could be found between two groups over the course of study. But for VAS during movement, the 0.125B group showed more satisfactory results especially during early postoperative periods. For the incidence of complications, the 0.125B group revealed greater frequency of sensory change (25.0%) and motor blockade (10.0%) compared with the 0.0625B group. Conclusion: This study suggests that 0.0625% bupivacaine with morphine via epidural route was sufficient for pain control during rest but it was not satisfactory during movement especially in early postoperative periods. We also recommend that careful attention to motor blockade should be paid when using 0.125% bupivacaine.

• The Korean Journal of Pain
• /
• v.12 no.1
• /
• pp.64-69
• /
• 1999

Background: The new drug HP228 is a cytokine restraining agent with a broad spectrum of anti-inflammatory, analgesic, and antipyretic activity. Six healthy, adult, male volunteers were studied to determine the independent and interactive effects of HP228 and morphine on pain perception. Methods: Two groups of stimuli were applied to each volunteers before drug administration as control, 20 min after morphine and HP228 administration, and 20 min after combined administration of these two drugs. Two adhesive electrically-conducting pads were applied on opposite sides of the arm approximately 8 cm apart. The electrode were connected to an electrical impulse generator and 50 Hz 1 msec pulses of incrementally increasing intensity were delivered at 1 sec intervals. The analgesic endpoints were the current intensity (mA) at which the subject first detected the stimulus (THRESH), the intensity at which the stimulus was first idenfied as being painful (PAIN), and the intensity at which the subject requested that the stimulus be terminated due to discomfort (LIMIT). A second series of stimuli were applied immediately thereafter using 1-sec duration 50 Hz tetanus pulses with increasing intensities at 2~5 sec intervals. Results: There were significant differences between drug treatments (Morphine, HP228, HP228/Morphine) and control (No drugs) in any of the measurements (PAIN, LIMIT) except THRESH with the twitch and tetanus test. Conclusions: The data suggests that HP228 is an analgesic, but it does not appear to interact with morphine in an additive manner.

• Economic and Environmental Geology
• /
• v.26 no.4
• /
• pp.507-518
• /
• 1993

Paleomagnetic investigations have been carried out on the Tertiary sedimentary formations (Yeonil Group) in Pohang basin, southeastern Korea. A total of 215 samples were collected from 26 sites. Progressive thermal demagnetization indicates that many samples have unstable magnetization and do not reveal a characteristic direction. However, some samples from the lower and upper Duho Formation show a characteristic direction $D/I=7.8^{\circ}/48.3^{\circ}$ (${\alpha}_{95}=3.7^{\circ}$, k=174.1). Stepwise thermal demagnetization data show that some samples from the Hagjeon and middle Duho Formations reveal great-circle distributions moving from the present to a reversed direction of geomagnetic field. The mean of intersection points of the great-circles is nearly antipodal to the characteristic normal direction of the lower and upper Duho Formation. We infer that the Hagjeon Formation was formed during the reversed polarity chron C5B (16.2~14.7 Ma) and the Duho Formation 14.7~11.6 Ma based on our results and previous paleontologic and age dating data. Paleomagnetic direction for the Middle Miocene of Korea, analysed from the combined results of stable endpoints and great circles, is $D/I=8.7^{\circ}/53.9^{\circ}$ (${\alpha}_{95}=4.2^{\circ}$, k=74.8), and the corresponding paleopole is Lat./Long.=$82.7^{\circ}/230.2^{\circ}$ (${\delta}p=2.8^{\circ}$, ${\delta}m=5.9^{\circ}$). On the basis of this, we interpret that the opening of the East sea (Japan sea) or the synchronous clockwise rotation of the Southwest Japan exerted no structural influence on the Yeonil Group in the Middle Miocene.